Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA05 TACROLIMUSUM CAPS. ELIB. PREL 0,5 mg ADVAGRAF 0,5 mg 0,5 mg ASTELLAS PHARMA GMBH
PROGRAF(R) 0,5 mg 0.5 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CAPS. 1 mg PROGRAF(R) 1 mg 1 mg ASTELLAS IRELAND CO. LTD. L04AA05 TACROLIMUSUM CAPS. ELIB. PREL. 1 mg ADVAGRAF 1 mg 1 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CAPS. 5 mg PROGRAF(R) 5 mg 5 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CAPS. ELIB. PREL. 5 mg ADVAGRAF 5 mg 5 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CONC. PT. SOL. PERF. 5 mg/ml PROGRAF(R) 5 mg/ml 5 mg/ml ASTELLAS PHARMA GMBH ________________________________________________________________________________
| 914 |L04AA06| MYCOPHENOLATUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 180 mg MYFORTIC 180 mg 180 mg NOVARTIS PHARMA GMBH
CELLCEPT 1 mg/5 ml 1 g/5 ml ROCHE REGISTRATION LTD. L04AA06 MYCOPHENOLATUM CAPS. 250 mg CELLCEPT 250 mg 250 mg ROCHE REGISTRATION LTD. MYFENAX 250 mg 250 mg TEVA PHARMA BV
MYFORTIC 360 mg 360 mg NOVARTIS PHARMA GMBH L04AA06 MYCOPHENOLATUM CAPS. 500 mg MYFENAX 500 mg 500 mg TEVA PHARMA BV L04AA06 MYCOPHENOLATUM COMPR. FILM. 500 mg CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD. L04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. 500 mg SOL. PERF. CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 915 |L04AA08| DACLIZUMABUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA08 DACLIZUMABUM CONC. PT. SOL. PERF. 5 mg/ml ZENAPAX 5 mg/ml 5 mg/ml ROCHE REGISTRATION LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 916 |L04AA10| SIROLIMUS** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA10 SIROLIMUS COMPR. FILM. 1 mg RAPAMUNE 1 mg 1 mg WYETH EUROPA LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 917 |L04AA11| ETANERCEPTUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg SOL INJ
ENBREL 50 mg 50 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM SOL. INJ. IN SERINGA 25 mg PREUMPLUTA ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTA ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 918 |N02AX02| TRAMADOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ N02AX02 TRAMADOLUM COMPR. ELIB. MODIF. 100 mg TRAMADOLOR(R) 100 ID 100 mg HEXAL AG
NOAX UNO 100 mg 100 mg LABOPHARM EUROPE LIMITED TRALGIT SR 100 100 mg ZENTIVA AS TRAMADOL(R) RETARD 100 mg KRKA D.D. N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 100 mg PREL.
TRAMAL RETARD 100 mg 100 mg GRUNENTHAL GMBH N02AX02 TRAMADOLUM SOL. INJ. 100 mg MABRON 100 mg MEDOCHEMIE LTD. TRADOLAN 100 mg LANNACHER HEILMITTEL GMBH
TRADOLAN 100 mg LANNACHER HEILMITTEL GMBH TRAMADOL 100 mg KRKA D.D. TRAMAG 100 100 mg MAGISTRA C & C TRAMAL(R) 100 mg GRUNENTHAL GMBH
TRALGIT 100 100 mg/2 ml ZENTIVA A.S. Prescriere limitată: Tratamentul de scurtă durată al durerii acute N02AX02 TRAMADOLUM PIC. ORALE, SOL. 100 mg/ml TRALGIT 100 mg/ml ZENTIVA A.S. N02AX02 TRAMADOLUM SOL. ORALA 100 mg/ml TRADOLAN 100 mg/ml LANNACHER HEILMITTEL GMBH N02AX02 TRAMADOLUM COMPR. ELIB. PREL 150 mg TRALGIT SR 150 150 mg ZENTIVA AS N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 150 mg PREL.
TRAMADOL RETARD 150 mg 150 mg KRKA D.D. NOVO MESTO TRAMAL RETARD 150 mg 150 mg GRUNENTHAL GMBH N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 200 mg NOAX UNO 200 mg 200 mg LABOPHARM EUROPE LIMITED TRALGIT SR 200 200 mg ZENTIVA AS
PREL.
TRAMADOL RETARD 200 mg 200 mg KRKA D.D. NOVO MESTO TRAMAL RETARD 200 mg 200 mg GRUNENTHAL GMBH N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 300 mg NOAX UNO 300 mg 300 mg LABOPHARM EUROPE LIMITED N02AX02 TRAMADOLUM CAPS. 50 mg K-ALMA(R) 50 mg ANTIBIOTICE SA MABRON 50 mg 50 mg MEDOCHEMIE LTD. TRALGIT 50 50 mg ZENTIVA A.S. TRAMACALM 50 mg AC HELCOR SRL TRAMADOL 50 mg KRKA D.D. TRAMADOL LPH 50 mg 50 mg LABORMED PHARMA SA TRAMADOL AL 50 50 mg ALIUD(R) PHARMA GMBH & CO. KG TRAMADOL ARENA 50 mg ARENA GROUP S.A. TRAMAL(R) 50 mg GRUNENTHAL GMBH URGENDOL 50 mg MEDICAROM GROUP SRL N02AX02 TRAMADOLUM COMPR. 50 mg TRAMADOL 50 mg 50 mg OZONE LABORATORIES LTD. TRAMADOL EEL 50 mg BIO EEL SRL TRAMAG 50 50 mg MAGISTRA C & C N02AX02 TRAMADOLUM COMPR. FILM. 50 mg TRADOLAN 50 mg 50 mg LANNACHER HEILMITTEL GMBH N02AX02 TRAMADOLUM SOL. INJ. 50 mg TRADOLAN 50 mg 50 mg LANNACHER HEILMITTEL GMBH Prescriere limitată: Tratamentul de scurtă durată al durerii acute N02AX02 TRAMADOLUM SOL. INJ. 50 mg/ml TRALGIT 50 50 mg/ml ZENTIVA A.S. TRAMADOL 50 mg/ml KRKA D.D. TRAMADOL(R) AL 100 Fiole 50 mg/ml ALIUDR(R) PHARMA GMBH & CO. KG TRAMAL(R) 100 50 mg/ml GRUNENTHAL GMBH TRAMAL(R) 50 50 mg/ml GRUNENTHAL GMBH URGENDOL 50 mg/ml MEDICAROM GROUP SRL Prescriere limitată: Tratamentul de scurtă durată al durerii acute N02AX02 TRAMADOLUM PIC. ORALE, SOL. TRAMADOL AL PICĂTURI ALIUD PHARMA GMBH & CO. KG N02AX02 TRAMADOLUM PICATURI ORALE - SOL. 100 mg/ml TRAMAL(R) 100 mg/ml GRUNENTHAL GMBH ________________________________________________________________________________
| 919 |R05CB13| DORNAZA ALFA** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ R05CB13 DORNAZA ALFA SOL. INHAL 1 mg/ml PULMOZYME 1 mg/ml ROCHE ROMANIA S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 920 |V03AC03| DEFERASIROXUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ V03AC03 DEFERASIROXUM COMPR. DISP. 125 mg EXJADE 125 mg 125 mg NOVARTIS EUROPHARM LTD.
EXJADE 250 mg 250 mg NOVARTIS EUROPHARM LTD. V03AC03 DEFERASIROXUM COMPR. DISP. 500 mg EXJADE 500 mg 500 mg NOVARTIS EUROPHARM LTD. ________________________________________________________________________________
| 921 |V03AF01| MESNUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ V03AF01 MESNUM SOL. INJ. 400 mg/4 ml UROMITEXAN(R) 400 mg 400 mg/4 ml BAXTER ONCOLOGY GMBH ________________________________________________________________________________ SUBLISTA C2 - P9: PROGRAM NAŢIONAL DE TRANSPLANT DE ORGANE, ŢESUTURI ŞI CELULE DE ORIGINE UMANĂ. P9.2: TRANSPLANT DE CORD ______________________________________________________________________________ | 922 |B01AB08| REVIPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB08 REVIPARINUM SOL. INJ. 1432 ui/0.25 ml CLIVARIN(R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG
CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG ________________________________________________________________________________
| 923 |B05AA06| POLYGELINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B05AA06 POLYGELINUM SOL. PERF. 3.5% HAEMACCEL 3.5% THERASELECT GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 924 |C01CA24| EPINEPHRINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C01CA24 EPINEPHRINUM SOL. INJ. 1 mg/ml ADRENALINA 1 mg 1 mg/ml TERAPIA SA ________________________________________________________________________________ ______________________________________________________________________________ | 925 |J01CR05| PIPERACILLINUM + TAZOBACTAMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR05 PIPERACILLINUM + LIOF. PT. SOL. INJ. TAZOBACTAMUM TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 926 |J01DD12| CEFOPERAZONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 1 g LYZONE 1 g 1 g MEDICAROM GROUP S.R.L. MEDOCEF 1 g 1 g MEDOCHEMIE LTD. J01DD12 CEFOPERAZONUM PULB. PT. SOL. INJ. 2 g LYZONE 2 g 2 g MEDICAROM GROUP S.R.L. MEDOCEF 2 g 2 g MEDOCHEMIE LTD.
CEFOZON 500 mg 500 mg E.I.P.I.CO. MED S.R.L. J01DD12 CEFOPERAZONUM PULB. PT. SOL. 1 g INJ./PERF. I.M./I.V. CEFOZON 1 g 1 g E.I.P.I.CO. MED S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 927 |J01DH51| IMIPENEMUM + CILASTATINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01DH51 IMIPENEMUM + PULB. PT. SOL. PERF. CILASTATINUM TIENAM I.V. MERCK SHARP & DOHME ROMANIA S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 928 |J01XX08| LINEZOLIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA 100 mg/5 ml ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG
ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG J01XX08 LINEZOLIDUM COMPR. FILM. 600 mg ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 929 |J02AC01| FLUCONAZOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC01 FLUCONAZOLUM CAPS. 100 mg DIFLAZON 100 mg 100 mg KRKA D.D. FLUCONAZOLE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL FLUCORIC 100 mg 100 mg TERAPIA S.A. FLUCOVIM 100 100 mg VIM SPECTRUM SRL FUNGOLON 100 mg 100 mg BALKANPHARMA RAZGRAD AD
DIFLAZON 150 mg 150 mg KRKA D.D. DIFLUCAN 150 mg 150 mg PFIZER EUROPE MA EEIG FLUCONAZOL 150 mg 150 mg OZONE LABORATORIES LTD. FLUCONAZOL MEDICO UNO 150 mg 150 mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150 mg MEDOCHEMIE ROMANIA SRL FLUCONAZOL SANDOZ(R) 150 150 mg SANDOZ SRL FLUCONAZOL TERAPIA 150 mg 150 mg TERAPIA SA FLUCONAZOLE TEVA 150 mg 150 mg TEVA PHARMACEUTICALS SRL FLUCORIC 150 mg 150 mg TERAPIA S.A. FLUCOVIM 150 150 mg VIM SPECTRUM SRL MYCOMAX 150 150 mg ZENTIVA AS MYCOSYSTA(R) 150 mg 150 mg GEDEON RICHTER PLC. J02AC01 FLUCONAZOLUM CAPS. 200 mg DIFLAZON 200 mg 200 mg KRKA D.D. FLUCONAZOLE TEVA 200 mg 200 mg TEVA PHARMACEUTICALS SRL
DIFLAZON(R) 2 mg/ml KRKA D.D. DIFLUCAN(R) 2 mg/ml PFIZER EUROPE MA EEIG MYCOMAX(R) INF 2 mg/ml ZENTIVA AS J02AC01 FLUCONAZOLUM CAPS. 50 mg DIFLAZON 50 mg 50 mg KRKA D.D. DIFLUCAN 50 mg 50 mg PFIZER EUROPE MA EEIG FLUCONAZOL 50 mg 50 mg ARENA GROUP SA FLUCONAZOL MEDOCHEMIE 50 mg 50 mg MEDOCHEMIE ROMANIA SRL FLUCONAZOL SANDOZ(R) 50 50 mg SANDOZ SRL FLUCONAZOL TERAPIA 50 mg 50 mg TERAPIA S.A. FLUCONAZOLE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL FLUCORIC 50 mg 50 mg TERAPIA S.A. FLUCOVIM 50 50 mg VIM SPECTRUM SRL FUNGOLON 50 mg 50 mg BALKANPHARMA RAZGRAD AD
DIFLUCAN(R) 50 mg/5 ml 50 mg/5 ml PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 930 |J02AC03| VORICONAZOLUM** | Protocol: J012B | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC03 VORICONAZOLUM COMPR. FILM. 200 mg VFEND 200 mg 200 mg PFIZER LTD.
VFEND 200 mg 200 mg PFIZER LTD. J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALA 40 mg/ml VFEND 40 mg/ml 40 mg/ml PFIZER LTD. J02AC03 VORICONAZOLUM COMPR. FILM. 50 mg VFEND 50 mg 50 mg PFIZER LTD. ________________________________________________________________________________
| 932 |J05AB14| VALGANCICLOVIRUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL ________________________________________________________________________________ ______________________________________________________________________________ | 933 |L04AA01| CICLOSPORINUM | | |_______|_______|____________________________________________|_________________|
Monitorizarea atentă a pacienţilor este obligatorie. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA01 CICLOSPORINUM CAPS. MOI 100 mg EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS S.R.O.
EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 25 mg CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 50 mg CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 935 |L04AA05| TACROLIMUSUM** | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|